Medicine and Dentistry
Tenascin
100%
Patient
57%
Myocardial Infarction
57%
Heart Function
42%
Tissues
39%
Cardioplegia
36%
Dipeptidyl Carboxypeptidase
33%
Pseudoephedrine Plus Triprolidine
31%
Human Serum Albumin
31%
Odds Ratio
31%
Limb
31%
Athletic Training
31%
Infarction
28%
Metalloprotease Inhibitor
28%
Gelatinase B
27%
Aortic Valve Replacement
26%
Age
22%
Gelatinase A
19%
Prosthetics
19%
Mortality
18%
Myocardium
18%
Follow up
16%
Left Ventricular Hypertrophy
15%
Heart Ventricle Remodeling
15%
Heart
15%
Upregulation
15%
Magnetic Resonance Imaging
14%
Experience
14%
Health Care Cost
14%
Geriatrics
13%
Plasma
13%
Blood
13%
Collagen Type 1
13%
Enalapril Maleate
11%
Prosthesis
11%
Death
11%
Cardiomyocyte
10%
Cardiac Fibrosis
10%
Median Sternotomy
10%
Inpatient
10%
Stress
10%
Aortic Constriction
9%
Marker
9%
Renal Failure
9%
Myocardial Protection
9%
Apoplexy
9%
Life
9%
Combination Therapy
8%
Fibroblast
8%
Messenger RNA
8%
Biochemistry, Genetics and Molecular Biology
Tenascin C
100%
Heart Function
35%
Training
31%
Age
22%
Angiotensin-Converting Enzyme
21%
Pig
19%
Matrix Metalloproteinase
19%
Knockout Mouse
17%
Electric Potential
15%
Mouse
15%
Sheep
15%
Animal Models
14%
Collagen
12%
Dilatation
12%
Enzyme Activity
11%
Upregulation
11%
Magnetic Resonance Imaging
11%
Animal
11%
Wild Type Mouse
10%
Experience
10%
Fibroblast
8%
Pressure
8%
Messenger RNA
8%
Association
8%
Skill
7%
Wild Type
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tenascin
97%
Heart Infarction
35%
Abdominal Aortic Aneurysm
31%
Ischemic Mitral Valve Regurgitation
23%
Pig
19%
Sheep
15%
Mouse
14%
Collagen Type 1
13%
Infarction
13%
Knockout Mouse
10%
Tissue Inhibitor of Metalloproteinase
9%
Heart Left Ventricle Hypertrophy
8%
Toll Like Receptor 4
7%
Animal
7%
Fibrosis
7%
Protein C
7%
Dipeptidyl Carboxypeptidase
5%
